Insider Ledger
Schwab Charles Corp. (SCHW) insider buying and SEC filings
Schwab Charles Corp. · CIK 316709
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE, NYSE, NYSE
- Industry (SIC)
- Security Brokers, Dealers & Flotation Companies
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$1.8M
Insiders who bought
1
Sold (not marked 10b5-1)
$194.7M
Planned sales (10b5-1)
$35.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 2, 2026 | Planned (10b5-1) | Neesha Hathi (MD, Head Wealth Adv, Bnk, Tst) sold 5,000 shares indirectly (by trust) at about $88.92 ($445K), marked as a 10b5-1 plan trade. Holdings by trust down 46% to 5,770 shares. | SEC filing Filed Nov 3, 2026, 5:29 PM ET |
| Oct 28–29, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 203,150 shares indirectly (by trust) between Oct 28 and Oct 29 at about $89.12 ($18.1M). Holdings by trust down <1% to 53,346,291 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 29, 2026, 7:23 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Neesha Hathi (MD, Head Wealth Adv, Bnk, Tst) sold 5,000 shares indirectly (by trust) at about $97.80 ($489K), marked as a 10b5-1 plan trade. Holdings by trust down 46% to 5,770 shares. | SEC filing Filed Oct 5, 2026, 4:01 PM ET |
| Sep 1, 2026 | Planned (10b5-1) | Neesha Hathi (MD, Head Wealth Adv, Bnk, Tst) sold 3,177 shares indirectly (by trust) at about $109.04 ($346K), marked as a 10b5-1 plan trade. Holdings by trust down 36% to 5,770 shares. | SEC filing Filed Sep 2, 2026 |
| Aug 28, 2026 | Planned (10b5-1) | Neesha Hathi (MD, Head Wealth Adv, Bnk, Tst) sold 3,177 shares indirectly (by trust) at about $108.12 ($343K), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Aug 31, 2026 |
| Aug 26, 2026 | Sale | Carolyn Schwab-Pomerantz (Director) sold 9,175 shares indirectly (by trust) at about $109.25 ($1.0M). Holdings by trust down 1% to 1,323,162 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| Aug 24, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 117,000 shares indirectly (by trust) at about $113.20 ($13.2M). Holdings by trust down <1% to 53,558,741 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 17, 2026 | Sale | Jonathan S Beatty (MD, Head of Advisor Services) sold 1,000 shares indirectly (by trust) at about $111.33 ($111K). Holdings by trust down 9% to 10,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| Aug 14, 2026 | Planned (10b5-1) | Jonathan M. Craig (MD, Head of Retail Investing) sold 21,866 shares indirectly (by trust) at about $111.03 ($2.4M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Aug 17, 2026 |
| Aug 13, 2026 | Planned (10b5-1) | Dennis Howard (MD, Chief Tech, OPS & Data Off) sold 2,198 shares at $110.00 ($242K), marked as a 10b5-1 plan trade. Holdings down 24% to 6,980 shares. | SEC filing Filed Aug 17, 2026 |
| Aug 12, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 46,410 shares indirectly (by entity) at about $108.18 ($5.0M). Holdings by entity down <1% to 30,021,463 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Aug 11, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 46,445 shares indirectly (by entity) at about $107.78 ($5.0M). Holdings by entity down <1% to 30,067,873 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Sale | Paula A. Sneed (Director) sold 5,263 shares indirectly (by trust) at about $107.15 ($564K). Holdings by trust down 5% to 91,711 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 6–10, 2026 | Planned (10b5-1) | Nigel J Murtagh (Chief Risk Officer) sold 26,675 shares between Aug 6 and Aug 10 at about $109.01 ($2.9M), marked as a 10b5-1 plan trade. Holdings down 32% to 57,972 shares. | SEC filing Filed Aug 10, 2026 |
| Aug 5, 2026 | Sale | Carolyn Schwab-Pomerantz (Director) sold 18,561 shares indirectly (by trust) at about $107.70 ($2.0M). Holdings by trust down 1% to 1,332,337 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Jonathan M. Craig (MD, Head of Retail Investing) sold 21,750 shares indirectly (by trust) at about $107.02 ($2.3M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 4, 2026 | Sale | Carolyn Schwab-Pomerantz (Director) sold 22,640 shares indirectly (by trust) at about $106.36 ($2.4M). Holdings by trust down 2% to 1,350,898 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3–4, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 142,900 shares indirectly (by trust) between Aug 3 and Aug 4 at about $105.71 ($15.1M). Holdings by trust down <1% to 53,877,941 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| Jul 28, 2026 | Sale | Carolyn Schwab-Pomerantz (Director) sold 22,650 shares indirectly (by trust) at about $105.71 ($2.4M). Holdings by trust down 2% to 1,373,809 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 28, 2026 | Planned (10b5-1) | Dennis Howard (MD, Chief Tech, OPS & Data Off) sold 28,000 shares at about $105.01 ($2.9M), marked as a 10b5-1 plan trade. Holdings down 73% to 10,470 shares. | SEC filing Filed Jul 30, 2026 |
| Jul 28–29, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 143,450 shares indirectly (by entity) between Jul 28 and Jul 29 at about $105.75 ($15.2M). Holdings by entity down <1% to 30,114,318 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Nigel J Murtagh (Chief Risk Officer) sold 32,947 shares at about $104.01 ($3.4M), marked as a 10b5-1 plan trade. Holdings down 36% to 57,972 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 24, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 45,500 shares indirectly (by trust) at $101.72 ($4.6M). Holdings by trust down <1% to 54,128,841 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 28, 2026 |
| Jul 23, 2026 | Sale | Peter J. Morgan III (General Counsel) sold 6,952 shares at about $102.03 ($709K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 27, 2026 |
| Jul 21, 2026 | Planned (10b5-1) | Nigel J Murtagh (Chief Risk Officer) sold 4,053 shares at about $104.14 ($422K), marked as a 10b5-1 plan trade. Holdings down 7% to 57,972 shares. | SEC filing Filed Jul 23, 2026 |
| Jul 21, 2026 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 2,000 shares indirectly (by trust) at about $104.21 ($208K), marked as a 10b5-1 plan trade. Holdings by trust down 15% to 11,738 shares. | SEC filing Filed Jul 21, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Jonathan M. Craig (MD, Head of Retail Investing) sold 21,750 shares indirectly (by trust) at about $102.01 ($2.2M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Jul 9, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 2,000 shares indirectly (by trust) at about $102.01 ($204K), marked as a 10b5-1 plan trade. Holdings by trust down 13% to 13,738 shares. | SEC filing Filed Jul 8, 2026 |
| Jul 2–6, 2026 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 4,000 shares indirectly (by trust) between Jul 2 and Jul 6 at about $98.52 ($394K), marked as a 10b5-1 plan trade. Holdings by trust down 20% to 15,738 shares. | SEC filing Filed Jul 6, 2026 |
| May 28, 2026 | Purchase (code P) | Richard A Wurster (CEO and Director) bought 21,959 shares at about $84.23 ($1.8M), reported as a purchase (code P). Holdings up 11% to 218,409 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| May 19, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 27,500 shares indirectly (by entity) at about $92.22 ($2.5M). Holdings by entity down <1% to 30,209,768 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
| May 18, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 27,500 shares indirectly (by entity) at about $92.40 ($2.5M). Holdings by entity down <1% to 30,237,268 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 4–6, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 218,600 shares indirectly (by entity) between May 4 and May 6 at about $91.76 ($20.1M). Holdings by entity down 1% to 30,264,768 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 6, 2026 |
| Apr 29–May 1, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 168,743 shares indirectly (by trust) between Apr 29 and May 1 at about $91.33 ($15.4M). Holdings by trust down <1% to 54,389,641 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 1, 2026 |
| Apr 23–27, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 72,900 shares indirectly (by trust) between Apr 23 and Apr 27 at about $90.25 ($6.6M). Holdings by trust down <1% to 55,673,384 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 27, 2026 |
| Apr 14–15, 2026 | Planned (10b5-1) | Paul V Woolway (MD, Chief Banking Officer) sold 15,883 shares indirectly (by trust) between Apr 14 and Apr 15 at about $99.00 ($1.6M), marked as a 10b5-1 plan trade. Holdings by trust down 35% to 29,866 shares. | SEC filing Filed Apr 16, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Jonathan M. Craig (MD, Head of Retail Investing) sold 21,750 shares indirectly (by trust) at about $99.00 ($2.2M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Apr 15, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Nigel J Murtagh (Chief Risk Officer) sold 41,297 shares at about $99.00 ($4.1M), marked as a 10b5-1 plan trade. Holdings down 42% to 57,972 shares. | SEC filing Filed Apr 15, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Dennis Howard (MD, Chief Tech, OPS & Data Off) sold 10,108 shares at about $94.60 ($956K), marked as a 10b5-1 plan trade. Holdings down 49% to 10,470 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Jonathan M. Craig (MD, Head of Investor Services) sold 14,481 shares indirectly (by trust) at about $94.60 ($1.4M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Nigel J Murtagh (Chief Risk Officer) sold 7,203 shares at about $94.61 ($681K), marked as a 10b5-1 plan trade. Holdings down 11% to 57,972 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 2–3, 2026 | Planned (10b5-1) | Paul V Woolway (MD, Chief Banking Officer) sold 22,010 shares indirectly (by trust) between Mar 2 and Mar 3 at about $94.97 ($2.1M), marked as a 10b5-1 plan trade. Holdings by trust down 42% to 29,866 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Sale | Jonathan S Beatty (MD, Head of Advisor Services) sold 2,030 shares indirectly (by trust) at about $95.30 ($193K). Holdings by trust down 9% to 19,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 26, 2026 | Sale | Stephen A Ellis (Director) sold 10,725 shares indirectly (by trust) at about $96.57 ($1.0M). Holdings by trust down 11% to 87,563 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 25, 2026 | Planned (10b5-1) | Dennis Howard (MD, Chief Tech, OPS & Data Off) sold 27,903 shares at about $95.02 ($2.7M), marked as a 10b5-1 plan trade. Holdings down 73% to 10,470 shares. | SEC filing Filed Feb 27, 2026 |
| Feb 9–10, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 158,613 shares indirectly (by entity) between Feb 9 and Feb 10 at about $106.35 ($16.9M). Holdings by entity down 1% to 30,483,368 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 3–4, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 164,600 shares indirectly (by trust) between Feb 3 and Feb 4 at about $103.77 ($17.1M). Holdings by trust down <1% to 55,782,729 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 5, 2026 |
| Jan 29, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 145,650 shares indirectly (by trust) at about $103.16 ($15.0M). Holdings by trust down <1% to 55,947,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 2, 2026 |
| Jan 28, 2026 | Sale | Charles R. Schwab (Chair and Director) sold 71,437 shares indirectly (by trust) at about $103.21 ($7.4M). Holdings by trust down <1% to 56,092,979 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 28, 2026 |
| Jan 22, 2026 | Sale | Carolyn Schwab-Pomerantz (Director) sold 42,865 shares indirectly (by trust) at about $105.20 ($4.5M). Holdings by trust down 3% to 1,396,459 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 26, 2026 |
| Jan 22, 2026 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 2,000 shares indirectly (by trust) at about $105.00 ($210K), marked as a 10b5-1 plan trade. Holdings by trust down 8% to 21,768 shares. | SEC filing Filed Jan 23, 2026 |
| Dec 23, 2025 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 2,000 shares indirectly (by trust) at about $102.01 ($204K), marked as a 10b5-1 plan trade. Holdings by trust down 14% to 11,923 shares. | SEC filing Filed Dec 29, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Jonathan S Beatty (MD, Head of Advisor Services) sold 3,072 shares indirectly (by trust) at $98.00 ($301K), marked as a 10b5-1 plan trade. Holdings by trust down 20% to 11,923 shares. | SEC filing Filed Nov 14, 2025 |
101 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SCHW in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.